Preclinical development of a non-toxic oral formulation of monoethanolamine, a lipid precursor, for prostate cancer treatment
Saved in:
Published in | Clinical cancer research Vol. 23; no. 14; pp. 3781 - 3793 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
06.02.2017
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1078-0432 |
---|---|
DOI: | 10.1158/1078-0432.CCR-16-1716 |